The American University in Cairo (AUC) and Minapharm have agreed to create what AUC calls the first African academy for biotechnology. The initiative begins early this year and aims to bridge a long-standing gap between academic training and industry needs.
The partners will share expertise through joint workshops, research projects, conferences and specialist lectures. At first, training will focus on postgraduate biotechnology students and on practical, hands-on skills such as biopharmaceutical manufacturing, quality control and regulatory compliance.
AUC will develop the curriculum and supervise the academic side, while Minapharm will co-develop course content, deliver specialised training and host trainees at its industrial facilities. The academy may later expand to other fields like engineering and business administration.
Difficult words
- academy — a school or center for higher learning
- biotechnology — use of biology in industry and medicine
- postgraduate — study after finishing a first university degree
- curriculum — the set of courses and their content
- quality control — checks to make sure products meet standards
- regulatory compliance — following official rules and legal requirements
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think practical, hands-on training is useful for students? Why or why not?
- Would you prefer training at a university or at an industrial facility? Explain briefly.
- Should the academy later include fields like engineering or business administration? Why?
Related articles
Savar declared a degraded airshed over severe air pollution
The Department of Environment declared Savar a degraded airshed after monitoring found annual air pollution nearly three times the national standard of 35 micrograms per cubic meter. The decision responds to pollution from brick kilns, factories, transport and construction and new rules start September 2025.
Study finds Abbott-Bioline malaria test gives many false negatives
A study on the Thailand–Myanmar border found the Abbott-Bioline rapid malaria test missed many infections. Researchers call it “not fit for purpose”; WHO and the manufacturer are reviewing the test and further studies are under way.
